Arcadia Biosciences Q3 EPS $(2.04) Misses $(0.77) Estimate, Sales $392K Beat $290K Estimate

Arcadia Biosciences (NASDAQ:RKDA) reported quarterly losses of $(2.04) per share which missed the analyst consensus estimate of $(0.77) by 164.94 percent. This is a 319.35 percent decrease over earnings of $0.93 per

Benzinga · 11/06/2019 21:45

Arcadia Biosciences (NASDAQ:RKDA) reported quarterly losses of $(2.04) per share which missed the analyst consensus estimate of $(0.77) by 164.94 percent. This is a 319.35 percent decrease over earnings of $0.93 per share from the same period last year. The company reported quarterly sales of $392 thousand which beat the analyst consensus estimate of $290 thousand by 35.17 percent. This is a 5.95 percent increase over sales of $370 thousand the same period last year.